Macquarie Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,978
Closed -$144K 2205
2022
Q3
$144K Sell
6,978
-1,027
-13% -$13.5K ﹤0.01% 1677
2022
Q2
$77K Buy
8,005
+6,978
+679% +$87.6K ﹤0.01% 1941
2022
Q1
$17 Hold
1,027
﹤0.01% 2428
2021
Q4
$17K Sell
1,027
-1,346
-57% -$22.1K ﹤0.01% 2437
2021
Q3
$39K Sell
2,373
-2,472
-51% -$26.9K ﹤0.01% 2304
2021
Q2
$31K Buy
+4,845
New +$31.3K ﹤0.01% 2263
2020
Q2
Sell
-11,225
Closed -$39K 2415
2020
Q1
$39K Buy
+11,225
New +$65.6K ﹤0.01% 1842
2019
Q1
Sell
-1,147
Closed -$1K 2136
2018
Q4
$1K Sell
1,147
-31,954
-97% -$61.9K ﹤0.01% 2230
2018
Q3
$78K Sell
33,101
-159,499
-83% -$398K ﹤0.01% 1643
2018
Q2
$526K Sell
192,600
-13,900
-7% -$38.3K ﹤0.01% 1348
2018
Q1
$566K Buy
206,500
+167,600
+431% +$486K ﹤0.01% 1348
2017
Q4
$121K Buy
38,900
+23,900
+159% +$67.2K ﹤0.01% 1867
2017
Q3
$42K Buy
+15,000
New +$40.5K ﹤0.01% 2021

Other funds holding ISEE

Macquarie Group's ISEE Position: Q4 2022 in Review

Macquarie Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 6,978 shares — an estimated $144K sold.

Macquarie Group first reported a position in ISEE in Q3 2017 and held it in 13 quarters. The position peaked at $566K in Q1 2018. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Macquarie Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 6,978 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $144K.
  • Macquarie Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
  • Macquarie Group's IVERIC bio, Inc. Common Stock position peaked at $566K in Q1 2018.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.